Skip to main content

Refine your results

Filters
Search
Include spaces in matter number if applicable. Ex.: 182 3125
Date
Displaying 23901 - 23920 of 45459
Advocacy Filings

FTC and Department of Justice Comment to the Hon. Helene E. Weinstein Concerning New York A.B. A01837 to Establish that Certain Real Estate Services May be Provided Only by Attorneys

Date
Matter Number
V070004
Related Release
Federal Register Notice Issued on Authorized Generic Drug Study; FTC/DOJ File Joint Comments with NY State Assembly Committee on the Unauthorized Practice of Law
Advocacy Filings

FTC Staff Comment to the Hon. Nelie Pou Concerning New Jersey A.B. A-310 to Regulate Contractual Relationships Between Pharmacy Benefit Managers and Health Benefit Plans

Date
Matter Number
V060019
Federal Trade Commission Statement Concerning Reliance on Prior PBM-Related Adv…
Related Release
FTC Staff Files Comments with New Jersey Assemblywoman on PBM Legislation; Commission Seeks Public Comments on Orders to Collect Information on Food Marketing
FTC Votes to Issue Statement Withdrawing Prior Pharmacy Benefit Manager Advocacy
Cases and Proceedings

Thermo Electron Corporation, In the Matter of

The consent order settled charges that Thermo Electron Corporation’s proposed $12.8 billion acquisition of Fisher Scientific International, Inc. would harm competition in the U.S. market for high-performance centrifugal vacuum evaporators (CVEs). Thermo and Fisher are the only two significant suppliers of high-performance CVEs in the United States and the proposed transaction would eliminate the direct price, service, and innovation competition that exists between them. To settle the Commission’s charges, Thermo is required to divest Fisher’s Genevac division, which includes Fisher’s entire CVE business, within five months of the date the consent agreement was signed.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
0610187
Displaying 23901 - 23920 of 45459
Return to top